Hi Terry, the impression I got from talking with Dr Chick and his feedback from talking with surgeons is that the CardioCel patch had the strength/flexibility/no calcification issues to be considered as an ideal patch for the repair of heart valves.
We also saw evidence of this in an earlier ann. from the company (14/08/2014……)
“Our sales teams have been able to generate considerable interest for CardioCel® from surgeons globally, particularly with our strong pre-clinical data and successful patient outcomes to date. Bringing our facility into production is very exciting to us and allows us to continually expand our reach by bringing CardioCel® to our customers for the repair and reconstruction of cardiac defects, including the repair of heart valves” said Mr. Rodne.
To date, CardioCel® has been used in a range of cardiovascular repair and reconstruction procedures in both adults and paediatrics, including hole-in-the-heart repairs and heart valve reconstructions. Recently, in the US, CardioCel® has been used in less-invasive robotic surgery to repair defective heart valves which is a major step forward for the use of CardioCel® in cardiovascular surgery.
- Forums
- ASX - By Stock
- 12 Months To Look Forward To…...
Hi Terry, the impression I got from talking with Dr Chick and...
-
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 681 | $17.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.25 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 681 | 17.900 |
1 | 1 | 17.800 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
18.250 | 100 | 1 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
18.750 | 143 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online